Brad E. Hoffman
Impact in
Papers in
- Genetics 20
- Virus-based gene therapy research 20
-
- CRISPR and Genetic Engineering 7
- Viral Infectious Diseases and Gene Expression in Insects 5
- RNA Interference and Gene Delivery 5
- Co-authors
- Roland W. Herzog (21 shared papers)David M. Markusic (8 shared papers)Cox Terhorst (10 shared papers)Sushrusha Nayak (6 shared papers)Geoffrey D. Keeler (9 shared papers)Emilia L. Oleszak (3 shared papers)Ou Cao (5 shared papers)B. Paul Morgan (1 shared paper)
- Journals
- Molecular Therapy (7 papers)Cellular Immunology (3 papers)Molecular Therapy — Methods & Clinical Development (3 papers)Blood (2 papers)Human Gene Therapy (2 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Brad E. Hoffman
35 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 74
- Genetics 971
- Oncology 504
- Hematology 209
- Immunology 368
- Developmental Neuroscience 63
Countries citing papers authored by Brad E. Hoffman
This map shows the geographic impact of Brad E. Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad E. Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad E. Hoffman more than expected).
Fields of papers citing papers by Brad E. Hoffman
This network shows the impact of papers produced by Brad E. Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad E. Hoffman. The network helps show where Brad E. Hoffman may publish in the future.
Co-authors
The 25 scholars most cited alongside Brad E. Hoffman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 336 | |
| 2 | 2010 | 127 | |
| 3 | 2010 | 113 | |
| 4 | 2009 | 102 | |
| 5 | 2013 | 101 | |
| 6 | 2017 | 100 | |
| 7 | 2016 | 97 | |
| 8 | 2009 | 85 | |
| 9 | 2009 | 78 | |
| 10 | 2017 | 76 | |
| 11 | 2019 | 63 | |
| 12 | 2017 | 63 | |
| 13 | 2009 | 60 | |
| 14 | 2011 | 59 | |
| 15 | 2014 | 59 | |
| 16 | 2017 | 59 | |
| 17 | 2016 | 58 | |
| 18 | 2015 | 54 | |
| 19 | 2009 | 49 | |
| 20 | 2015 | 45 |
About Brad E. Hoffman
Brad E. Hoffman is a scholar working on Genetics, Molecular Biology, Oncology, Immunology and Infectious Diseases, having authored 35 papers that have together received 2.0k indexed citations. Recurring topics across this work include Virus-based gene therapy research (20 papers), CAR-T cell therapy research (14 papers), Immunotherapy and Immune Responses (8 papers), CRISPR and Genetic Engineering (7 papers), Viral gastroenteritis research and epidemiology (6 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), T-cell and B-cell Immunology (5 papers) and RNA Interference and Gene Delivery (5 papers). The work is most often cited by research in Genetics (971 citations), Oncology (504 citations), Hematology (209 citations), Immunology (368 citations) and Developmental Neuroscience (63 citations). Brad E. Hoffman has collaborated with scholars based in United States, China and France. Frequent co-authors include Roland W. Herzog, David M. Markusic, Cox Terhorst, Sushrusha Nayak, Geoffrey D. Keeler, Emilia L. Oleszak, Ou Cao, B. Paul Morgan, John W. Prineas and Eunice E. Kwon. Their work appears in journals such as Molecular Therapy, Cellular Immunology, Molecular Therapy — Methods & Clinical Development, Blood and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.